In the battle against deadly diseases that adapt quickly to resist today’s top antibiotics, researchers from the University of Nevada, Reno have shown that stopping bacterial cells from communicating can actually prevent them from amassing their lethal armies.
RENO, Nevada – In the battle against deadly diseases that adapt quickly to resist today’s top antibiotics, researchers from the University of Nevada, Reno have shown that stopping bacterial cells from communicating can actually prevent them from amassing their lethal armies.
Following more than five years of research, University chemical biologist Yftah Tal-Gan and his team successfully demonstrated that interrupting the deadly Streptococcus pneumoniae bacteria’s communicative mechanism could lead to significant advances in medicine, eventually saving countless lives. The team studied “quorum-sensing” bacteria that synchronize the activities of large groups of cells by communicating via chemical signal molecules. The potentially game-changing research has just been published in the prestigious Proceedings of the National Academy of Sciences.
Employing robotic, automated batch sampling and other testing on slightly modified configurations of peptides (chains of amino acids), the team recently synthesized a peptide shown effective on the two deadly strains of Streptococcus pneumoniae. The synthetic peptide developed by Tal-Gan’s team effectively cuts off the bacteria’s communication. In doing so, the synthetic peptide not only stops the bacteria’s potentially lethal attacks on the body; it also halts what is known as “selection pressure” – the process akin to natural selection through which the strongest bacteria survive to become drug-resistant.
Streptococcus pneumoniae attacks compromised or undeveloped immune systems, making the elderly and children especially vulnerable. It is blamed for over 22,000 deaths, 400,000 hospitalizations and $3.5 billion in health care costs annually in the United States alone – and an estimated 800,000 deaths globally among children age 5 and under.
Overcoming the challenge of drug resistance
“People don’t realize it, but bacteria are smart – they communicate, they adapt,” Tal-Gan said. “The big issue today is that Strep pneumoniae builds up resistance to drugs, making them stronger and rendering the antimicrobials ineffective. Through our research, we have synthesized peptides in a way that interrupts the bacteria’s communication, keeping them from rallying their harmful forces and from initiating resistance to drug therapies.”
Not only do bacteria communicate, they use the buddy system. “It makes sense that if you get a scratch, you’ll have a few bacteria in your bloodstream,” Tal-Gan explained. “Your strong immune system is going to kill them in a second. So instead, the bacteria are going to hide and build their army. It’s only when they reach critical mass (a “quorum”), when they know they have the numbers, that they begin synchronizing all together to start producing virulence (disease-producing) factors to overwhelm the immune system and establish an infection.”
By exploiting this mechanism, Tal-Gan’s team has demonstrated that it is possible to moderate or eliminate the bacteria’s disease-producing capability without killing them, preventing the unintended-but-certain resistances the world is grappling with today.
The findings are now being published within the international scientific community and the team has begun exploring avenues for deploying their new synthesized peptides as a therapeutic strategy, as a standalone or in combination with antibiotics or vaccines. The team has filed for a patent and is seeking funding and partners to optimize the molecules further and develop treatment strategies, including new pharmaceuticals to improve the desired therapeutic effects. That research is in its early stages, yet the science behind it is now proven to have merit. The next phase of research could elevate Tal-Gan’s team’s breakthrough to even higher levels.
“Like so much of what we do in the College of Science at the University of Nevada, Reno, the research of professor Tal-Gan and his entire team is high-value, high-impact science,” Jeff Thompson, the College’s dean, said. “Breakthrough discoveries like this don’t just happen. It takes resources, vision and a collaboration of smart people persisting daily to solve the world’s most critical challenges.”
Research team, funding
The research team was comprised of principal investigators Tal-Gan of the University of Nevada, Reno and Gee W. Lau, Tal-Gan’s collaborator from University of Illinois at Urbana-Champaign; Yifang Yang and Anthony Harrington, University of Nevada, Reno graduate students; Gabriel Cornilescu, staff scientist at National Magnetic Resonance Facility at Madison, Wisc., and Jingjun Lin, graduate student at UIUC.
A peptide chemist by training, Tal-Gan’s early interest in biology and chemistry eventually led to his ultimate passion. “I fell in love with bacterial communication, and that was it. I never looked back,” Tal-Gan said. “It’s just fascinating, so cool.” Tal-Gan joined the University’s College of Science in 2014, where he currently serves as an assistant professor.
The first five years of research by Tal-Gan’s team was funded by a bridge INBRE grant (IDeA Networks of Biomedical Research Excellence) from the National Institute of General Medical Science and a $1.8 million NIH R35 grant to the Tal-Gan lab. Last April, Tal-Gan and Lau jointly secured a $2 million National Institutes of Health (NIH) grant (National Heart, Lung and Blood Institute R01 grant) to provide up to four years to further develop and test the synthesized peptides.
– @unevadareno –
Photo cutline: Results of research by chemical biologist Yftah Tal-Gan and his team may lead to medical advances to aid the treatment or prevention of deadly bacterial diseases like Streptococcus pneumoniae in the future.
The University of Nevada, Reno, is a public research university that is committed to the promise of a future powered by knowledge. Nevada’s land-grant university founded in 1874, the University serves 21,000 students. The University is a comprehensive, doctoral university, classified as an R1 institution with very high research activity by the Carnegie Classification of Institutions of Higher Education. Additionally, it has attained the prestigious “Carnegie Engaged” classification, reflecting its student and institutional impact on civic engagement and service, fostered by extensive community and statewide collaborations. More than $800 million in advanced labs, residence halls and facilities has been invested on campus since 2009. It is home to the University of Nevada, Reno School of Medicine and Wolf Pack Athletics, maintains a statewide outreach mission and presence through programs such as the University of Nevada, Reno Extension, Nevada Bureau of Mines and Geology, Small Business Development Center, Nevada Seismological Laboratory, and is part of the Nevada System of Higher Education. Through a commitment to world-improving research, student success and outreach benefiting the communities and businesses of Nevada, the University has impact across the state and around the world. For more information, visit www.unr.edu.
Media Contact:
David Stipech
Communications Officer
University of Nevada, Reno/108
Reno, NV 89557
775-784-4720
dstipech@unr.edu
www.unr.edu/nevada-today
